aspirin has been researched along with ochratoxin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eraly, SA; Kaler, G; Khandelwal, A; Nagle, M; Nigam, SK; Swaan, PW; Truong, DM | 1 |
| Dirheimer, G; Grosse, Y; Obrecht-Pflumio, S; Pfohl-Leszkowicz, A | 1 |
2 other study(ies) available for aspirin and ochratoxin a
| Article | Year |
|---|---|
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
Topics: Binding Sites; Hydrophobic and Hydrophilic Interactions; Kinetics; Molecular Structure; Organic Anion Transport Protein 1; Organic Anion Transporters; Static Electricity; Substrate Specificity | 2007 |
Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney.
Topics: Animals; Anticarcinogenic Agents; Aspirin; DNA Adducts; DNA Damage; Indomethacin; Kidney; Kidney Neoplasms; Male; Mice; Ochratoxins; Urinary Bladder; Urinary Bladder Neoplasms | 1996 |